期刊文献+

酪氨酸激酶受体RON表达在子宫内膜腺癌发生发展中的意义 被引量:3

Significance of the Expression of Tyrosine Kinase Receptor RON in the Occurrence and Development Processes of Endometrial Adenocarcinoma
下载PDF
导出
摘要 目的研究酪氨酸激酶受体RON在子宫内膜腺癌中的表达及其与临床病理参数的关系。方法采用原位杂交和免疫组化方法分别检测20例正常子宫内膜组织、20例不典型增生子宫内膜组织、60例子宫内膜腺癌组织之间的RON mRNA和蛋白表达。结果不同子宫内膜组织间原位杂交单位面积平均光密度(OD)值分别为:正常子宫内膜0.422±0.132、不典型子增生宫内膜0.700±0.143、子宫内膜腺癌1.038±0.164。RON在正常子宫内膜和不典型增生子宫内膜与子宫内膜腺癌比较有统计学意义(P<0.01),但不典型增生子宫内膜与正常子宫内膜无统计学意义(P=0.631)。不同子宫内膜组织间免疫组化OD值分别为:正常子宫内膜0.474±0.223、不典型增生子宫内膜1.078±0.086、子宫内膜腺癌1.217±0.107。RON在正常子宫内膜、不典型增生子宫内膜与子宫内膜腺癌比较有统计学意义(P<0.01),不典型增生子宫内膜与正常子宫内膜相比较也有统计学意义(P=0.015)。RON mRNA和蛋白表达与子宫内膜腺癌临床分期、组织学分级及淋巴结转移有关(P<0.05),RON mRNA还与肌层浸润深度有关(P<0.01)。结论 RON的过度表达参与子宫内膜腺癌的发生、发展过程。 Objective To investigate the relation ship between tyrosine kinase receptor RON expression and clinicopathological pa- rameters, and observe the expression of RON in endometrial adenocarcinoma( EC). Methods The expression of RON mRNA and protein was studied in 20 cases of normal endometrium ,20 cases of atypical endometrial and 60 cases of endometrial adenocarcinoma by in situ hy- bridization and immunohistochemistry method. Results Average optical density (OD) of per unit area of in situ hybridization was 0. 422 ± 0. 132 in normal endometrium, 0. 700 ± 0. 143 in atypical endometrial and 1. 038 + 0. 164 in endometrial adenocarcinoma. It prompted that the expression of RON mRNA in normal endometrium and atypical endometrial each had statistical significance to that in endometrial adenocarcinoma (P 〈 0.01 ). But the expression of RON mRNA in normal endometrium had no statistical significance to that in atypical endometrial(P = 0. 631 ). Average optical density of per unit area of immunohistochemistry was 0. 474 ± 0. 223 in normal endometrium, 1. 078 ± O. 086 in atypical endometrial and 1. 217 ± 0. 107 in endometrial adenocarcinoma. It revealed that the expression of RON protein in normal endometrium and atypical endometrial each had statistical significance to that in endometrial adeuocarcinoma ( P 〈 0.01 ) , and there was statistical significance between normal endometrium and atypical endometrial as well(P = 0. 015). The statistical evaluation ex- posited that the expression rates of RON mRNA and RON protein had close relations with clinical stage, histologic grade as well as lym- phatic metastasis ( P 〈 0.05 ), had nothing to do with ages, menostasis and the depth of Infiltration in Musclar layer ( P 〉 O. 05 ), al- though the expression of RON mRNA was relevant to the depth of infiltration in Musclar layer ( P 〈 0.01 ). Conclusion Over - expression of RON plays a role in the occurrence and development processes of endometrial adenocarcinoma.
出处 《医学研究杂志》 2013年第2期70-74,共5页 Journal of Medical Research
基金 浙江省医药卫生科技计划项目(2010YKA175)
关键词 酪氨酸激酶受体RON 子宫内膜腺癌 原位杂交 免疫组化 Tyrosine kinase receptor RON Endometrial adenocarcinoma In situ hybridization Immunohistochemistry
  • 相关文献

参考文献10

  • 1王丽萍,郭科军.缺氧诱导因子-1与血管内皮生长因子在子宫内膜腺癌中的表达及与雌激素受体的相关性研究[J].临床误诊误治,2010,23(8):729-731. 被引量:11
  • 2Hanahan D,Weinberg RA. Hallmarks of cancer:the next generation[J].Cell,2011,(05):646-674.
  • 3余建平,曾晓明.酪氨酸激酶受体RON与非小细胞肺癌[J].中华肿瘤防治杂志,2010,17(3):224-227. 被引量:1
  • 4Wang MH,Wang D,Chen YQ. Oncogenic and invasive potentials of human macrophage-stimulating protein receptor,the RON receptor tyrosine kinase[J].Carcinogenesis,2003,(08):1291-1300.
  • 5Chen Q,Seol DW,Carr B. Coexpression and regulation of Met and Ron protooncogenes in human hepatocellular carcinoma tissues and cell lines[J].Hepatology,1997,(01):59-66.
  • 6Lu Y,Yao HP,Wang MH. Multiple variants of the RON receptor tyrosine kinase:biochemical properties,tumorigenic activities,and potential drug targets[J].Cancer Letters,2007,(02):157-164.
  • 7Ma Q,Zhang K,Guin S. Deletion or insertion in the first immunoglobulin-plexin-transcription (IPT) domain differentially regulates expression and tumorigenic activities of RON receptor Tyrosine Kinase[J].Molecular Cancer Therapeutics,2010,(09):307-322.
  • 8Ma Q,Zhang K,Yao HP. Inhibition of MSP-RON signaling pathway in cancer cells by a novel soluble form of RON comprising the entire semasequence[J].International Journal of Oncology,2010,(06):1551-1561.
  • 9Ponzetto C,Bardelli A,Zhen Z. A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family[J].Cell,1994,(02):261-271.
  • 10Meyer SE,Peace BE,Bahassiel M. Chk2 * 1100delC Acts in synergy with the Ron receptor tyrosine kinase to accelerate mammary tumorigenesis in mice[J].Cancer Letters,2010,(02):186-193.

二级参考文献35

  • 1Minna J D, Fong K, Zochbauer M S, et al. Molecular pathogenesis of lung cancer and potential translational applications[J]. Cancer J,2008,8(Suppl 1):41-46.
  • 2杜友谊.肺癌组织中酪氨酸激酶受体RON的表达及意义[D].中国优秀硕士学位论文全文数据库,2009,7(10):293-298.
  • 3Maggiora P, Marehio S, Stella M C, et al. Overexpression of the RON gene in human breast careinoma[J]. Oneogene, 2008,16 (13) :2927-2933.
  • 4Zhou Y Q,He C,Chen Y Q,et al. Altered expression of the RON receptor tyrosine kinase in primary human coloreetal adenocareinomas:generation of different splicing variants and their oncogenic potential[J]. Oncogene,20030229(11) :186-197.
  • 5Matzke A, Herrlich P, Ponta H, et al. A five-amino-acid peptide blocks Met- and RON dependent cell migration[J]. Cancer Res, 2008,65(14) :6105-6110.
  • 6Wang M H, Wang D A, Chen Y Q. Oncogenic and invasive potentials of human Macrophage-stimulating protein receptor, the RON receptor tyrosine kinase[J]. Carcinogenesis, 2008,23 (13) : 1291-1300.
  • 7Palmarini M, Fan H. Retrovirus-induced ovine pulmonary adenocarcinoma,an animal model for lung cancer[J]. J Natl Cancer Inst,2007,93(3) :1603-1614.
  • 8Dusty M, Neal S V, Shan L L. Transformation and scattering activities of the receptor tyrosine kinase RON/Stk in rodent fibroblasts and lack of regulation by the jaagsiekte sheep retrovirus receptor, Hyal2[J]. BMC Cancer, 2004,4 (6) : 64.
  • 9Christopher G W, David I S, Wang M H, et al. Differential screening of a human chromosome 8 library identifies hepatocyte growth factor-like/macrophage-stimulating protein and its receptor in injured lung[J]. J Clin Invest, 2007,99 (10) : 2979-2991.
  • 10Christopher G, Willett, Wang M H, et al. Maerophage-stimulating protein and its receptor in non-small cell lung tumors: Induction of receptor tyrosine phosphorylation and cell migration[J]. Am J Respir Cell Mol Biol, 2008,18 (2) : 489-496.

共引文献10

同被引文献10

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部